Naltrexone — Nutrient Associations & Health Patterns

Also known as: Naltrexone / Low Dose Naltrexone — LDN (ReVia, Vivitrol, Contrave)

Drug Class: Opioid antagonist / Immunomodulator (LDN)

Full opioid antagonist used at standard doses (50mg/day) for alcohol use disorder and opioid use disorder. At ultra-low doses (1.5–4.5mg/day) used off-label as 'Low Dose Naltrexone' (LDN) for autoimmune conditions, fibromyalgia, Crohn's disease, MS, chronic pain, and mood disorders. LDN's mechanism differs from standard dosing — it transiently blocks opioid receptors causing a rebound increase in endorphin production and modulates microglia to reduce neuroinflammation. Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.

Medication and Nutrition Context

Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.

Common Side Effects of Naltrexone

Key Drug Interactions — Naltrexone

Naltrexone has 5 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:

Frequently Asked Questions

What nutrient associations are reported for Naltrexone?

Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.

Which nutrient relationships are mapped for Naltrexone?

Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.

What are the side effects of Naltrexone?

Common side effects associated with Naltrexone include: Standard dose (50mg): Nausea (most common early), headache, fatigue, sleep disturbances, loss of appetite; LDN (1.5–4.5mg): Vivid dreams or sleep disturbances (most common early side effect), transient nausea; Liver toxicity risk (standard doses — baseline liver function required); Precipitation of opioid withdrawal (if opioids present in system at initiation); Depression (rare — opioid system modulation).

Explore Related Health Intelligence